Nexalis Therapeutics: Half Yearly Report and Accounts

Aug 31, 2026 at 3:57 AM EDT · Issued by Nexalis Therapeutics Limited via ASX

Filed with ASX · Aug 31, 2026 at 3:57 AM EDT

On 6ix: 6ix.com/news/half-yearly-report-and-accounts-790

Nexalis Therapeutics Ltd Appendix 4D Half-year report 1. Company details Name of entity: Nexalis Therapeutics Ltd ABN: 90 611 845 820 Reporting period: For the half-year ended 30 June 2026 Previous period: For the half-year ended 30 June 2025 2. Results for...

View Attachment

6ix hasn’t read this filing yet.

Nexalis Therapeutics Limited on 6ix

Story so far

Half Yearly Report and AccountsAug 25, 2025

Earlier from Nexalis Therapeutics

Jun26 Appendix 4C Cash Flow ReportJul 30
Jun26 Quarterly Activities ReportJul 30
Change in substantial holdingJul 29
Update on Funding Facility and Clinical ProgramJul 5
Binding Letter of Intent to replace existing $53m facilityMay 27

Later from Nexalis Therapeutics

Removal of draft wording in the directors report HY accountsSep 1
Chair Appointment/ResignationOct 1
Initial Director's Interest Notice - Niv DaganOct 5
Final Director's Interest Notice - Sean WilliamsOct 5
Change of Director's Interest Notice - Darryl DaviesOct 5

All Nexalis Therapeutics news releases

Follow Nexalis Therapeutics into a list and get an email when it puts out news.

Follow Nexalis Therapeutics